ReviewEuropean journal of cancer (Oxford, England : 1990)2022

Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article.

Jérôme Barrière et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.